COVID-19 in multiple sclerosis patients and risk factors for severe infection-Reference-Cited by-同舟云学术

COVID-19 in multiple sclerosis patients and risk factors for severe infection

Published:2020-11 Issue: Volume:418 Page:117147
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Chaudhry Farhan,Bulka Helena,Rathnam Anirudha S.,Said Omar M.,Lin Jia,Lorigan Holly,Bernitsas Eva,Rube Jacob,Korzeniewski Steven J.,Memon Anza B.,Levy Phillip D.,Schultz Lonni,Javed Adil,Lisak Robert,Cerghet Mirela

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference19 articles.

1. Hospital admission due to infections in multiple sclerosis patients;Montgomery;Eur. J. Neurol.,2013

2. COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?;Novi;Mult. Scler. Relat. Disord.,2020

3. An Italian programme for COVID-19 infection in multiple sclerosis;Sormani;Lancet Neurol.,2020

4. COVID-19 in MS;Bowen;Neurol. Neuroimmunol. Neuroinflammation,2020

5. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up;Runmarker;Brain,1993

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 Vaccination;Vaccines;2024-08-19

2. De-escalation and Discontinuation of Disease-Modifying Therapies in Multiple Sclerosis;Current Neurology and Neuroscience Reports;2024-07-12

3. A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic;Journal of Neurology;2024-06-27

4. Infektionen und Multiple Sklerose;Fortschritte der Neurologie · Psychiatrie;2024-05-08

5. Long-Term Observation of SARS-CoV-2 Vaccination Response upon High Efficacy Treatment in Multiple Sclerosis—A Real-World Scenario;Vaccines;2024-03-12